The role of elastases secreted by fibroblasts in wrinkle formation: implication through selective inhibition of elastase activity.
We have previously demonstrated that decreases in skin elasticity, accompanied by increases in the tortuosity of elastic fibers, are important early events in wrinkle formation. In order to study the role of elastases in the degeneration of elastic fibers during wrinkle formation we examined the effects of an inhibitor of skin fibroblast elastase, N-phenethylphosphonyl-L-leucyl-L-tryptophane (NPLT), on wrinkle formation in hairless mice skin following UV irradiation. Dorsal skins of hairless mice were exposed daily to UV light for 18 weeks at doses of 65-95 mJ/cm2 and treated topically with 100 microL of 1 mM NPLT immediately after each UV irradiation. Wrinkles on dorsal skins were evaluated from week 6 through week 18. The daily exposure of mouse skin to UV light with less than 1 minimal erythemal dose significantly enhanced the activity of elastase in the exposed skin by week 4, and the elevated levels of elastase activity were significantly reduced by the in vitro incubation with NPLT in a dose-dependent manner to a level similar to that in unexposed mice skin, indicating that NPLT can efficiently inhibit the UV-inducible elastase activity. Topical application of NPLT significantly suppressed wrinkle formation when compared with vehicle controls by week 15 of treatment (P < 0.05). Histochemistry of elastic fibers with Orcein staining demonstrated that there were no obvious decreases of the fine elastic fibers in UV-exposed NPLT-treated skin in contrast to their marked decreases in the UV-exposed vehicle-treated skin. These findings suggest that skin fibroblast elastase plays a decisive role in wrinkle formation through the degeneration of elastic fiber.
Tsuji
N
N
Biological Science Laboratories, Kao Corporation, 2606, Akabane, Ichikai, Haga, Tochigi 321-3497, Japan.
Moriwaki
S
S
Suzuki
Y
Y
Takema
Y
Y
Imokawa
G
G
D000818:Animals; D004151:Dipeptides / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005347:Fibroblasts / Q000201:enzymology / Q000528:radiation effects; D006801:Humans; D051379:Mice; D008812:Mice, Hairless; D008813:Mice, Inbred ICR; D063065:Organophosphonates / Q000494:pharmacology; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012867:Skin / Q000201:enzymology* / Q000473:pathology / Q000528:radiation effects; D015595:Skin Aging / Q000473:pathology / Q000502:physiology* / Q000528:radiation effects; D014466:Ultraviolet Rays / Q000009:adverse effects
D004151:Dipeptides; D004791:Enzyme Inhibitors; C437343:N-phenethylphosphonyl-leucyl-tryptophan; D063065:Organophosphonates; D010196:Pancreatic Elastase